Dose-dependent effects of siRNA-mediated inhibition of SCAP on PCSK9, LDLR, and plasma lipids in mouse and rhesus monkey.
about
Physiological and therapeutic regulation of PCSK9 activity in cardiovascular disease.Developmental and extrahepatic physiological functions of SREBP pathway genes in mice.Cholesterol auxotrophy and intolerance to ezetimibe in mice with SREBP-2 deficiency in the intestine.New insights into ANGPLT3 in controlling lipoprotein metabolism and risk of cardiovascular diseases.
P2860
Dose-dependent effects of siRNA-mediated inhibition of SCAP on PCSK9, LDLR, and plasma lipids in mouse and rhesus monkey.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dose-dependent effects of siRN ...... ds in mouse and rhesus monkey.
@en
Dose-dependent effects of siRN ...... ds in mouse and rhesus monkey.
@nl
type
label
Dose-dependent effects of siRN ...... ds in mouse and rhesus monkey.
@en
Dose-dependent effects of siRN ...... ds in mouse and rhesus monkey.
@nl
prefLabel
Dose-dependent effects of siRN ...... ds in mouse and rhesus monkey.
@en
Dose-dependent effects of siRN ...... ds in mouse and rhesus monkey.
@nl
P2093
P2860
P356
P1476
Dose-dependent effects of siRN ...... ds in mouse and rhesus monkey.
@en
P2093
Ablatt Mahsut
CarolAnn Keohan
David Coelho
David G McLaren
Gail Forrest
James Hubert
Karen O Akinsanya
Kithsiri B Herath
Kristian K Jensen
P2860
P304
P356
10.1194/JLR.M071498
P577
2016-10-05T00:00:00Z